--- title: What a Time to Be Alive description: Three 2026 breakthroughs, a personalized cancer vaccine, a pancreatic cancer drug and thousands of new planets, and the engineering that made each one real image: https://www.southgeeks.com/hubfs/What%20a%20time.png --- [![South Geeks\_ orange-1](https://www.southgeeks.com/hubfs/South%20Geeks_%20orange-1.svg "South Geeks_ orange-1")](https://www.southgeeks.com/) [![South Geeks\_deep blue and orange](https://www.southgeeks.com/hubfs/South%20Geeks_deep%20blue%20and%20orange.svg "South Geeks_deep blue and orange")](https://www.southgeeks.com/) - [OUR SERVICES](https://www.southgeeks.com/services) - [ABOUT US](https://www.southgeeks.com/about) - [OUR WORK](https://www.southgeeks.com/our-work) - [CAREERS](https://www.southgeeks.com/careers) More results [Let's Talk](https://www.hubspot.com/) [LET'S TALK](https://www.southgeeks.com/contact) [LET'S TALK](https://www.hubspot.com/) - [OUR SERVICES](https://www.southgeeks.com/services) - [ABOUT US](https://www.southgeeks.com/about) - [OUR WORK](https://www.southgeeks.com/our-work) - [CAREERS](https://www.southgeeks.com/careers) [Buy Now](https://www.hubspot.com/) [South Geeks](https://www.southgeeks.com/news/tag/south-geeks)[AI](https://www.southgeeks.com/news/tag/ai) # What a Time to Be Alive [![Julia Duran](https://app.hubspot.com/settings/avatar/25be2089cd6284ab2e3e4ade9274e120)](https://www.southgeeks.com/news/author/julia-duran) by [Julia Duran](https://www.southgeeks.com/news/author/julia-duran) 3 min read Oct 1, 2026, 2:00:06 PM What a time to be alive. Aside from the many scary things we can think of about tech and society these days, medicine and science just had one of their best runs in years. Three stories landed within a few months of each other this past summer, and each one on its own would have been the story of the year a decade ago. A vaccine built for one person On August 19, Moderna and Merck announced that their personalized melanoma vaccine succeeded in a large late-stage trial. It's a vaccine built from your own tumor. Here's how it works. A patient's tumor gets sequenced and compared against their healthy blood cells, and an algorithm ranks hundreds of candidate mutations to select up to 34 that the immune system is most likely to recognize. Those get encoded into an mRNA vaccine made for that one person, paired with Merck's Keytruda to boost the response. Earlier Phase 2 data from this same program showed 68.8% of patients stayed cancer-free at five years, versus 49.1% on immunotherapy alone. A 49% cut in recurrence risk. The pill that cracked a 40-year problem Shortly after, on August 26, the FDA approved daraxonrasib for pancreatic cancer. It targets KRAS, the mutated protein behind roughly 90% of pancreatic cancer cases, using what NPR described as a molecular glue that binds several mutated forms at once. Scientists had called KRAS undruggable for 40 years. In a 500-patient trial, people on the drug survived a median of 13.2 months, almost double the 6.7 months on chemotherapy. One trial participant, former Senator Ben Sasse, saw a 76% reduction in tumor volume and called it a miracle drug. A telescope's worth of planets  found in weeks instead of years The third story has nothing to do with medicine. A team led by Princeton doctoral candidate Joshua Roth trained a machine learning model to comb through 80 million light curves captured by NASA's TESS satellite, and found more than 10,000 new planet candidates: over 9,000 gas giants, more than 100 Neptune-size planets and 11 potential super-Earths. Vetting that much data by hand would have taken an estimated 3.5 years. With the model doing the heavy lifting, the team finished in weeks. "It is safe to say this search would not have been possible without the machine learning step," Roth said. The engineering underneath each breakthrough Behind the vaccine is a pipeline that takes a biopsy, sequences it, runs the model, manufactures a custom batch of mRNA, quality-checks it and ships it fast enough to matter for a patient who doesn't have time to wait. Behind the pill is a 500-patient trial run across dozens of sites, with the data held together well enough to prove, beyond argument, that it actually extends life. Behind the planet search is the infrastructure that let a small team run a model across 80 million light curves without the project taking years. That infrastructure is what turns a promising result into something real: a vaccine a patient can actually receive, a drug the FDA can approve, a planet candidate other astronomers can confirm. The same pattern, everywhere technology meets execution This isn't unique to these three stories. It's the pattern behind almost every "AI is transforming X" headline right now: the model gets built faster than ever, and the integration, the compliance sign-off and the testing that never looks like the demo are what actually take the time. Gartner has been tracking this same gap in enterprise AI: 75% of organizations are piloting or already deploying some form of AI agents, and only 15% are even considering fully autonomous ones. What decides whether the science or the model actually reaches people is whether anyone built the engineering underneath it strong enough to hold real weight. Where South Geeks fits This is the layer we specialize in. At South Geeks, we build embedded engineering teams for health, life sciences and fintech companies sitting at exactly this point, where the breakthrough is real, and what closes the gap to production is the engineering bandwidth to get it there safely, under the compliance and scale requirements regulated industries actually live under. The teams that get to write the next headline are the ones who also built the engineering underneath this one. If your team is sitting on something promising and short on the engineering hours to get it across the finish line, let's talk about what that actually takes. Share this [Share on X](https://x.com/intent/post?url=https://www.southgeeks.com/news/what-a-time-to-be-alive&text=What+a+Time+to+Be+Alive) [Share on Facebook](https://www.facebook.com/sharer/sharer.php?u=https://www.southgeeks.com/news/what-a-time-to-be-alive&t=What+a+Time+to+Be+Alive) [Share on LinkedIn](https://www.linkedin.com/shareArticle?mini=true&url=https://www.southgeeks.com/news/what-a-time-to-be-alive&t=What+a+Time+to+Be+Alive) Previous story [← The Cognitive Cost of AI (and Why It's Worth Paying Attention to Right Now)](https://www.southgeeks.com/news/the-cognitive-cost-of-ai-and-why-its-worth-paying-attention-to-right-now) ## You May Also Like These Related Stories [Mastering Engagement](https://www.southgeeks.com/news/mastering-engagement) ![](https://www.southgeeks.com/hubfs/u3433743128_Project_manager_working_with_team_adding_topics_i_c39937a0-d315-4d07-85bb-c64376f29ac9_2%20(1).png) [South Geeks](https://www.southgeeks.com/news/tag/south-geeks) ### Mastering Engagement Mar 5, 2024, 12:00:00 AM 1 min read [Fake Candidates: Why Detection Is a Core Part of How We Protect Our Clients](https://www.southgeeks.com/news/fake-candidates-why-detection-is-a-core-part-of-how-we-protect-our-clients) ![](https://www.southgeeks.com/hubfs/Imagen%20para%20Posteo.jpg) [AI](https://www.southgeeks.com/news/tag/ai) ### Fake Candidates: Why Detection Is a Core Part of How We Protect Our Clients Nov 5, 2025, 1:00:00 PM 2 min read [The AI Fluency Paradox in Tech Hiring](https://www.southgeeks.com/news/the-ai-fluency-paradox-in-tech-hiring) ![](https://www.southgeeks.com/hubfs/AI-Generated%20Media/Images/Collaborative%20Tech%20Discussion%20at%20Modern%20Office-1.png) [AI](https://www.southgeeks.com/news/tag/ai) ### The AI Fluency Paradox in Tech Hiring Jun 3, 2026, 1:00:00 PM 2 min read #### **About South Geeks** We are a nearshoring company that powers the evolution of technology with elite, AI-savvy talent from Latin America. [hello@southgeeks.com](mailto:hello@southgeeks.com) [Company LinkedIn](https://www.linkedin.com/company/southgeeks/?viewAsMember=true) [Inside South Geeks](https://www.southgeeks.com/about) - [About Us](https://www.southgeeks.com/about) - [Our Work](https://www.southgeeks.com/our-work) - [Our Offering](https://www.southgeeks.com/services) [Resources](https://www.southgeeks.com/news) - [News & Insights](https://www.southgeeks.com/news) - [GPT Explorer](https://chatgpt.com/g/g-6824e38056fc8191ae40bc8a24db11cc-south-geeks-explorer) - [Careers](https://www.southgeeks.com/careers) Copyright © 2026 South Geeks LLC. - [Terms](https://www.southgeeks.com/terms) - [Privacy](https://www.southgeeks.com/privacy) - [Sitemap](https://www.southgeeks.com/sitemap-guide) ```json { "@context" : "https://schema.org", "@type" : "BlogPosting", "author" : { "@type" : "Person", "name" : "Julia Duran", "url" : "https://www.southgeeks.com/news/author/julia-duran" }, "dateModified" : "2026-10-01T12:00:06.143Z", "datePublished" : "2026-10-01T12:00:06.000Z", "headline" : "What a Time to Be Alive", "image" : [ "https://www.southgeeks.com/hubfs/What%20a%20time.png" ], "mainEntityOfPage" : { "@id" : "https://www.southgeeks.com/news/what-a-time-to-be-alive", "@type" : "WebPage" }, "publisher" : { "@type" : "Organization", "logo" : { "@type" : "ImageObject", "url" : "https://www.southgeeks.com/hubfs/South%20Geeks_%20orange.svg" }, "name" : "South Geeks" } } ```